rxstat › Shortages › Rivaroxaban

Rivaroxaban (Xarelto) shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Rivaroxaban products have been discontinued in Canada. See the reports below for which products and when.

A blood thinner (factor Xa inhibitor) used to prevent and treat blood clots.

Products affected
0 / 1
Reports on file
1

Reports by product

Discontinued
XARELTO
15MG 20MG · TABLET KIT · BAYER INC
DIN 02441535

What's happening

One or more Rivaroxaban products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Rivaroxaban is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AF01).

Recent changes

Common questions

What is Rivaroxaban used for?

A blood thinner (factor Xa inhibitor) used to prevent and treat blood clots.

When will Rivaroxaban be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Rivaroxaban in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (antithrombotic agents)

Nadroparin (Fraxiparine) Widespread shortage 7 of 8 reported products affected Ticagrelor Widespread shortage 2 of 4 reported products affected · est. return Sep 25, 2026 Apixaban Partial shortage 1 of 10 reported products affected · est. return Jul 31, 2026 Bivalirudin (Angiomax) Partial shortage 1 of 3 reported products affected Clopidogrel (Plavix) Partial shortage 4 of 18 reported products affected · est. return Nov 10, 2026 Dabigatran Etexilate (Pradaxa) Partial shortage 2 of 6 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.